Coordinated Care to Optimize Cardiovascular Preventive Therapies in Type 2 Diabetes
Neha J. Pagidipati(Duke University), Jairo Cruz(Urology Team), Vanita R. Aroda(Brigham and Women's Hospital), John Covalesky(Urology Team), Alexander Paraschos(Urology Team), Melissa Magwire(Saint Luke's Health System), Christopher B. Granger(Clinical Research Institute), Kenneth Cohan(Urology Team), Jennifer B. Green, Rodica Pop‐Busui(University of Michigan), Jonathan Pak(Boehringer Ingelheim (United States)), Lisa A. Kaltenbach(Duke University), Priya Kumar(Urology Team), Çağrı Şenyücel(Eli Lilly (United States)), Eugenia Gianos(Urology Team), Abha Khandelwal(Urology Team), D.H. Schmidt(Urology Team), Michael E. Cohen(Urology Team), Dilip Viswanath(Urology Team), Ravikiran Korabathina(Urology Team), Drew A. Purdy(St. Michael's Hospital), S. Ejaz Ahmed(Urology Team), J. S. WALIA(Urology Team), Monica Leyva(Clinical Research Institute), James Michael Hochrein(Urology Team), Caroline R. Richardson(Brown University), Julienne K. Kirk(Wake Forest University), Adam J. Nelson(Clinical Research Institute), Abraham Salacata(Urology Team), Renato D. Lópes(Duke University), Rajendra H. Mehta(Manav Rachna International Institute of Research and Studies), Hussein R. Al‐Khalidi(Clinical Research Institute), Darren K. McGuire(Parkland Health & Hospital System), Roy Flood(Urology Team), Matthew A. Cavender, Keith Friedman(Urology Team), Julian Javier(Urology Team), Saurabh Sharma(Indo Soviet Friendship College of Pharmacy), Laura Webb(Duke University), Vikram Arora(G1 Therapeutics (United States)), Alexander Adler(Urology Team), Stuart Zarich(Urology Team), Nandkishore Ranadive(Urology Team), Patrick Weston(Urology Team), Carlos Bayron(Urology Team), Sharan Mahal(Urology Team), Ildiko Lingvay(Southwestern Medical Center), Linda Calhoun(Urology Team), Tanya Gaynor(Boehringer Ingelheim (United States))
Cited by 93
Related Papers
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
|New England Journal of Medicine|2023|2.6k
2. Classification and Diagnosis of Diabetes:<i>Standards of Care in Diabetes—2023</i>
|Diabetes Care|2022|2.4k
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2017|2.1k